首页 | 本学科首页   官方微博 | 高级检索  
     

地塞米松快速抑制卵巢癌细胞系ERK1/2活性
引用本文:Xia B,Lu J. 地塞米松快速抑制卵巢癌细胞系ERK1/2活性[J]. 癌症, 2002, 21(8): 868-871
作者姓名:Xia B  Lu J
作者单位:1. 广州军区广州总医院医学实验科
2. 第二军医大学病理生理学教研室,上海,00433
摘    要:
背景与目的:细胞外信号调节的激酶1/2(extracellularsignal-regulatedkinase1/2,ERK1/2)的激活在多种细胞增殖的过程中发挥重要作用。作者曾经发现人工合成的糖皮质激素地塞米松(dexamethasone,Dex)可显著抑制人卵巢癌细胞系HO-8910的增殖。本研究试图观察Dex对HO-8910细胞ERK1/2活性的影响,以探讨其抑制该细胞增殖的信号转导通路。方法:以Westernblot方法测定ERK1/2在HO-8910细胞中的活性,细胞计数方法检测细胞增殖的改变。结果:1×10-7mol/LDex作用于HO-8910细胞5min即出现ERK1和ERK2活性的同步降低,最大作用出现在30min,与对照相比,二者分别减少41%和54%(P均<0.001),4h恢复至对照水平。ERK1/2活性降低的程度随Dex浓度(1×10-10~1×10-6mol/L)升高而增大。该作用不能被糖皮质激素受体(glucocorticoidreceptor,GR)拮抗剂RU486所阻断。ERK1/2上游激酶MEK1/2的抑制剂PD98059也具有抑制该细胞增殖作用,并能增强Dex对细胞增殖的抑制。结论:Dex能够以不依赖GR的方式快速抑制HO-8910细胞ERK1/2活性,这可能与其抑制细胞增殖过程有关。

关 键 词:地塞米松 人卵巢癌细胞系 细胞外信号调节的激酶 细胞增殖
文章编号:1000-467X(2002)08-0868-04
修稿时间:2002-01-15

Rapid inhibition of extracellular signal-regulated kinase 1/2 in a human ovarian cancer cell line by dexamethasone
Xia Bing,Lu Jian. Rapid inhibition of extracellular signal-regulated kinase 1/2 in a human ovarian cancer cell line by dexamethasone[J]. Chinese journal of cancer, 2002, 21(8): 868-871
Authors:Xia Bing  Lu Jian
Affiliation:Department of Pathophysiology, Second Military Medical University, Shanghai 200433, P. R. China. xia-bing@21cn.com
Abstract:
BACKGROUND & OBJECTIVE: Activation of extracellular signal-regulated kinase 1/2 (ERK1/2) plays an important role in cell proliferation of a variety of cell types. The authors had previously found that dexamethasone (Dex), a synthetical glucocorticoid, can markedly inhibit the proliferation of a human ovarian cancer cell line HO-8910. This study was designed to observe the effect of Dex on the activation of ERK1/2 in HO-8910 cells in order to explore the signal transduction pathway that mediates the anti-proliferation effect of Dex on these cells. METHODS: The activation of ERK1/2 was determined by Western blot analysis, and changes of cell proliferation were examined by cell count. RESULTS: Inhibition of activation of ERK1 and ERK2 by 1 x 10(-7) mol/L Dex occurred synchronously at 5 min, with maximum up to 41% and 54%, respectively at 30 min compared with the control (P < 0.001), and sustained until 4 h. The effect increased with the increasement of concentration of Dex (1 x 10(-10)-1 x 10(-6) mol/L). RU486, an antagonist of glucocorticoid receptor (GR), did not block the effect. PD98059, an inhibitor of MEK1/2, also inhibited HO-8910 cell proliferation and could enhance the growth-inhibition effect of Dex. CONCLUSION: Dex can rapidly inhibit ERK1/2 activation in a GR-independent manner in HO-8910 cells, which might play a role in Dex-mediated growth inhibition.
Keywords:Dexamethasone  Human ovarian cancer cell line  Extracellular signal-regulated kinase  Cell proliferatio n
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号